2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine
C23H18F6N4O2S — CID 174961903
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine
2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine (PubChem CID 174961903) has the molecular formula C23H18F6N4O2S and a molecular weight of 528.48 g/mol. Its IUPAC name is 2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine.
Molecular Properties
| Compound Name | 2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine |
|---|---|
| PubChem CID | 174961903 |
| Molecular Formula | C23H18F6N4O2S |
| Molecular Weight | 528.48 g/mol |
| Exact Mass | 528.11 |
| IUPAC Name | 2-methylsulfinyl-4-[1-[[4-(trifluoromethoxy)phenyl]methyl]pyrrol-2-yl]-6-(trifluoromethyl)pyrimidine;pyridine |
| SMILES | CS(=O)c1nc(-c2cccn2Cc2ccc(OC(F)(F)F)cc2)cc(C(F)(F)F)n1.c1ccncc1 |
| InChI | InChI=1S/C18H13F6N3O2S.C5H5N/c1-30(28)16-25-13(9-15(26-16)17(19,20)21)14-3-2-8-27(14)10-11-4-6-12(7-5-11)29-18(22,23)24;1-2-4-6-5-3-1/h2-9H,10H2,1H3;1-5H |
| InChIKey | ZINWAPXIOGPHGN-UHFFFAOYSA-N |
| XLogP | 5.73 |
| TPSA | 69.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 528.48 |
| LogP ≤ 5 | 5.73 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174961903 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.